SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel Post author: Post published:December 12, 2023 Post category:uncategorized SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study. You Might Also Like Why people avoid looking at spiders March 9, 2026 Grant supports gene-editing research for rare metabolic diseases October 10, 2024 WHO and Saudi Arabia announce new digital health collaboration to support Hajj pilgrims October 22, 2024
WHO and Saudi Arabia announce new digital health collaboration to support Hajj pilgrims October 22, 2024